Patients with CTD, including Marfan syndrome (MFS), Ehlers–Danlos and Loeys–Dietz, are at higher risk of developing TAAD due to the widespread defects in the ECM composition via transforming growth factor-beta (TGF-β) signalling pathway upregulation [33]. Here, TGFB1 is linked to Marfan syndrome.